Joshua Ruch's Insider Trades & SAST Disclosures
Joshua Ruch's most recent trade in GeneDx Holdings Corp - Ordinary Shares - Class A was a trade of 5,816 Class A Common Stock done at an average price of $7.9 . Disclosure was reported to the exchange on Feb. 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Joshua Ruch.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.89 per share. | 05 Feb 2025 | 5,816 | 16,799 | - | 7.9 | 45,888 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2025 | 5,816 | 0 | - | - | Stock Option (right to buy) | |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 3,000 | 5,816 | - | - | Stock Option (right to buy) | |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.89 per share. | 17 Jan 2025 | 3,000 | 10,983 | - | 7.9 | 23,670 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2024 | 130 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2024 | 130 | 7,983 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 12,924 | 12,924 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 5,828 | 7,853 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 5,828 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 8,816 | 8,816 | - | - | Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 5,828 | 5,828 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 45,454 | 62,568 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 45,454 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.35 per share. | 27 Jan 2023 | 3,293,371 | 4,926,334 | - | 0.4 | 1,152,680 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.35 per share. | 27 Jan 2023 | 664,869 | 994,534 | - | 0.3 | 232,704 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.35 per share. | 27 Jan 2023 | 327,474 | 489,846 | - | 0.4 | 114,616 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 4,278 | 17,114 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 4,278 | 8,558 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 78,914 | 78,914 | - | - | Stock Option | |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 4.00 per share. | 29 Apr 2022 | 1,632,963 | 1,632,963 | - | 4 | 6,531,852 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 4.00 per share. | 29 Apr 2022 | 329,665 | 329,665 | - | 4 | 1,318,660 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 4.00 per share. | 29 Apr 2022 | 162,372 | 162,372 | - | 4 | 649,488 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2022 | 12,836 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2022 | 12,836 | 12,836 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 22,286 | 22,286 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 22,286 | 22,286 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 12,836 | 12,836 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 12,836 | 12,836 | - | - | Restricted Stock Unit |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges